Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |  Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 810Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

  Article Access Statistics

Year : 2021 | Volume:  12 | Issue Number:  2 | Page:  76-82

ORIGINAL ARTICLE

Impact of newer direct-acting antiviral drugs based on quality-adjusted life years: A prospective pharmacoeconomic study in hepatitis C patients
Vyas Bhavya H, Darji Nishita H, Rana Devang A, Vyas Kaushal Y, Malhotra Supriya D

Number of times this article was viewed 5364
Number of times this article has been printed  from the site 154
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0

 
  Feedback 
  Subscribe 
 Back To Article

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal
Sitemap | What's New Feedback | Copyright and Disclaimer | Privacy Notice
© Perspectives in Clinical Research | Published by Wolters Kluwer - Medknow
Online since 20th October, 2010